Rhythm Pharmaceuticals
Tracked across 3 events · 19 articles · First seen Feb 14, 2026 · Last active Jun 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Rhythm Pharmaceuticals is the defendant in a class action lawsuit, accused of making false and misleading statements regarding its CELLECTRA device and INO-3107 Biologics License Application.
Apr 01, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Rhythm Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard